Mounjaro (tirzepatide) is a medication primarily approved for managing type 2 diabetes. It works by improving blood sugar control and promoting weight loss.
As of now, Mounjaro is not officially approved for treating prediabetes. It is specifically indicated for individuals with type 2 diabetes. However, some healthcare providers may prescribe it off-label for prediabetes in certain cases.
While not standard, Mounjaro might be considered for individuals with prediabetes who:
If Mounjaro is not suitable, other strategies to manage prediabetes include: